Tilray, Inc. Note Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory note in the amount of $6,648,304 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc
Note Agreements
Tilray, Inc.
Pharmaceuticals
2025
Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Promissory note in the amount of $26,134,500 payable by 1945689 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Promissory note in the amount of $8,057,622 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $9,264,249.68 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $8,464,139.70 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $30,585,819.60 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $5,063,709.00 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Amended and Restated Senior Secured Convertible Note due 2026, dated July 12, 2022, issued and owing by HEXO to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Convertible Promissory Note due September 1, 2023, dated July 12, 2022, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Form of Convertible Note due September 1, 2023, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Form of Amended and Restated Senior Secured Convertible Note due 2026, issued and owing by HEXO Corp. to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022